These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20876562)

  • 1. Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa.
    MacLean RC; Perron GG; Gardner A
    Genetics; 2010 Dec; 186(4):1345-54. PubMed ID: 20876562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa.
    Hall AR; MacLean RC
    Evolution; 2011 Aug; 65(8):2370-9. PubMed ID: 21790582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistatic interactions between ancestral genotype and beneficial mutations shape evolvability in Pseudomonas aeruginosa.
    Gifford DR; Toll-Riera M; MacLean RC
    Evolution; 2016 Jul; 70(7):1659-66. PubMed ID: 27230588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of multiple drug resistance in Pseudomonas aeruginosa.
    Ward H; Perron GG; Maclean RC
    J Evol Biol; 2009 May; 22(5):997-1003. PubMed ID: 19298493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Resistance at No Cost: Rifampicin and Streptomycin a Dangerous Liaison in the Spread of Antibiotic Resistance.
    Durão P; Trindade S; Sousa A; Gordo I
    Mol Biol Evol; 2015 Oct; 32(10):2675-80. PubMed ID: 26130082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa.
    Qi Q; Toll-Riera M; Heilbron K; Preston GM; MacLean RC
    Proc Biol Sci; 2016 Jan; 283(1822):. PubMed ID: 26763710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.
    Schenk MF; Szendro IG; Salverda ML; Krug J; de Visser JA
    Mol Biol Evol; 2013 Aug; 30(8):1779-87. PubMed ID: 23676768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The consistency of beneficial fitness effects of mutations across diverse genetic backgrounds.
    Pearson VM; Miller CR; Rokyta DR
    PLoS One; 2012; 7(8):e43864. PubMed ID: 22937113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa.
    Hall AR; Griffiths VF; MacLean RC; Colegrave N
    Proc Biol Sci; 2010 Feb; 277(1681):643-50. PubMed ID: 19889704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The environment affects epistatic interactions to alter the topology of an empirical fitness landscape.
    Flynn KM; Cooper TF; Moore FB; Cooper VS
    PLoS Genet; 2013 Apr; 9(4):e1003426. PubMed ID: 23593024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental variation alters the fitness effects of rifampicin resistance mutations in Pseudomonas aeruginosa.
    Gifford DR; Moss E; MacLean RC
    Evolution; 2016 Mar; 70(3):725-30. PubMed ID: 26880677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminishing-returns epistasis among random beneficial mutations in a multicellular fungus.
    Schoustra S; Hwang S; Krug J; de Visser JA
    Proc Biol Sci; 2016 Aug; 283(1837):. PubMed ID: 27559062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa.
    MacLean RC; Buckling A
    PLoS Genet; 2009 Mar; 5(3):e1000406. PubMed ID: 19266075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
    Qi Q; Preston GM; MacLean RC
    mBio; 2014 Dec; 5(6):e01562. PubMed ID: 25491352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.
    Vogwill T; Kojadinovic M; MacLean RC
    Proc Biol Sci; 2016 May; 283(1830):. PubMed ID: 27170722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative epistasis between beneficial mutations in an evolving bacterial population.
    Khan AI; Dinh DM; Schneider D; Lenski RE; Cooper TF
    Science; 2011 Jun; 332(6034):1193-6. PubMed ID: 21636772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiosyncratic epistasis creates universals in mutational effects and evolutionary trajectories.
    Lyons DM; Zou Z; Xu H; Zhang J
    Nat Ecol Evol; 2020 Dec; 4(12):1685-1693. PubMed ID: 32895516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress.
    Rodríguez-Verdugo A; Gaut BS; Tenaillon O
    BMC Evol Biol; 2013 Feb; 13():50. PubMed ID: 23433244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power law fitness landscapes and their ability to predict fitness.
    Passagem-Santos D; Zacarias S; Perfeito L
    Heredity (Edinb); 2018 Nov; 121(5):482-498. PubMed ID: 30190560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminishing returns epistasis among beneficial mutations decelerates adaptation.
    Chou HH; Chiu HC; Delaney NF; Segrè D; Marx CJ
    Science; 2011 Jun; 332(6034):1190-2. PubMed ID: 21636771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.